Summers R J, Barnett D B, Nahorski S R
Life Sci. 1983 Sep 12;33(11):1105-12. doi: 10.1016/0024-3205(83)90667-7.
The alpha-2-adrenoceptor antagonist (3H)-rauwolscine has been used to label adrenoceptors in membranes from human cerebral cortex. The radioligand binds with high affinity (KD 2.08 nM) to a single population of sites with a density of 135 fmoles/mg protein. Adrenoceptor antagonists displaced binding in a simple monomolecular fashion with an order of affinity rauwolscine greater than yohimbine greater than phentolamine greater than corynanthine greater than prazosin indicating binding to alpha-2-adrenoceptors. Agonists displaced with an order of affinity clonidine greater than (-) adrenaline greater than (-) noradrenaline greater than dopamine greater than (-) isoprenaline but all displayed apparent Hill coefficients less than unity indicating heterogeneity of binding. The relatively high affinity of the alpha-1 antagonist prazosin for (3H)-rauwolscine binding sites in rat cerebral cortex was not observed in the human tissue which had pharmacological properties similar to those described previously in human platelet.
α-2-肾上腺素能受体拮抗剂(3H)-育亨宾已被用于标记人大脑皮质膜中的肾上腺素能受体。该放射性配体以高亲和力(KD 2.08 nM)与密度为135飞摩尔/毫克蛋白质的单一类型位点结合。肾上腺素能受体拮抗剂以简单的单分子方式取代结合,其亲和力顺序为育亨宾大于蛇根碱大于酚妥拉明大于柯楠因大于哌唑嗪,表明与α-2-肾上腺素能受体结合。激动剂取代的亲和力顺序为可乐定大于( - )肾上腺素大于( - )去甲肾上腺素大于多巴胺大于( - )异丙肾上腺素,但所有激动剂的表观希尔系数均小于1,表明结合存在不均一性。在人体组织中未观察到α-1拮抗剂哌唑嗪对大鼠大脑皮质中(3H)-育亨宾结合位点具有相对较高的亲和力,人体组织的药理特性与先前在人血小板中描述的相似。